IPP Bureau
Dr Reddy’s Q3FY22 PAT at Rs. 706 cr.
By IPP Bureau - January 28, 2022
Dr. Reddy's Laboratories has reported consolidated financial results for the period ended December 31, 2021
Covaxin and Covishield granted conditional market approval
By IPP Bureau - January 27, 2022
The vaccines are currently only authorised for emergency use in the country
Moderna working on Omicron-specific booster candidate
By IPP Bureau - January 27, 2022
This will evaluate the immunogenicity, safety, and reactogenicity of a single booster dose in adults aged 18 years and older
Mark Cuban’s online pharmacy set to disrupt drug prices in the US
By IPP Bureau - January 27, 2022
Direct to consumer pharmacy and formation as pharmacy benefit manager further mission to drastically expand access to affordable pharmaceuticals
Thermo Fisher Scientific earns NSF/ANSI 456 vaccine storage certification
By IPP Bureau - January 27, 2022
It meets stringent requirements for ensuring the safe storage and efficacy of temperature-sensitive vaccines, including those for Covid-19
Sun Pharma launches ophthalmic solution in Canada
By IPP Bureau - January 27, 2022
CEQUA’s nanomicellar (NCELL) technology improves the bioavailability and physicochemical stability of cyclosporine to increase ocular tissue penetration
Glenmark receives ANDA approval for hydrochlorothiazide tablets
By IPP Bureau - January 27, 2022
According to IQVIA sales data for the 12-month period ending November 2021, the Ziac tablets, 2.5 mg/6.25 mg, 5 mg/6.25 mg, and 10 mg/6.25 mg market achieved annual sales of approximately US $ 30.3 million
Botanical Solution Inc. raises $6.1 million in Series A
By IPP Bureau - January 27, 2022
The company develops sustainable botanical materials for agricultural and pharmaceutical applications
Cipla’s Q3FY22 PAT at Rs 729 cr.
By IPP Bureau - January 26, 2022
Cipla announced its unaudited consolidated financial results for quarter ended December 31st, 2021.
Mandaviya reviews public health preparedness to Covid-19
By IPP Bureau - January 26, 2022
Urges them to focus on tele-consultation like eSanjeevani and efficient monitoring of those in home isolation
Roche’s Evrysdi granted USFDA priority review for treatment of spinal muscular atrophy
By IPP Bureau - January 26, 2022
Evrysdi is approved in 70 countries and submitted in a further 31 with more than 4,500 patients treated to date
Torrent Pharmaceuticals consolidated PAT at Rs 249 cr
By IPP Bureau - January 26, 2022
Torrent Pharmaceuticals has reported consolidated financial results for the period ended December 31, 2021.
Quantori names Arun Nayar as Global Head of R&D Informatics
By IPP Bureau - January 26, 2022
New role strengthens Quantori’s global leadership position in data science & digital IT
.jpg "Polycarbin breaks the single-use scientific plastic mold")
Polycarbin breaks the single-use scientific plastic mold
By IPP Bureau - January 26, 2022
Closing the Loop on single-use plastics
.jpg "Intellect closes US $10 m Series A to scale mental healthcare across Asia")
Intellect closes US $10 m Series A to scale mental healthcare across Asia
By IPP Bureau - January 26, 2022
The oversubscribed round was led by New York-based HOF Capital and welcomed new investors including Headline, East Ventures, MS&AD Ventures, DG Daiwa Ventures, Pioneer Fund, as well as existing investor Insignia Ventures Partners
